Screening and management of portal hypertension in patients with advanced hepatocellular carcinoma in the era of immunotherapy
Hépato-Gastro & Oncologie Digestive · 2026-06 · 33 (6) · 694-699
DOI: 10.1684/hpg.2026.3179 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hépato-Gastro & Oncologie Digestive, 2026-06. Verfasst von Manon Allaire und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Allaire, M., Mouri, S., Bouzbib, C., Rudler, M., & Thabut, D. (2026). Screening and management of portal hypertension in patients with advanced hepatocellular carcinoma in the era of immunotherapy. Hépato-Gastro & Oncologie Digestive, 33(6), 694-699. https://doi.org/10.1684/hpg.2026.3179
Vancouver
Allaire M, Mouri S, Bouzbib C, Rudler M, Thabut D. Screening and management of portal hypertension in patients with advanced hepatocellular carcinoma in the era of immunotherapy. Hépato-Gastro & Oncologie Digestive. 2026;33(6):694-699. doi:10.1684/hpg.2026.3179
BibTeX
@article{Allaire2026,
author = {Allaire, Manon and Mouri, Sarah and Bouzbib, Charlotte and Rudler, Marika and Thabut, Dominique},
title = {Screening and management of portal hypertension in patients with advanced hepatocellular carcinoma in the era of immunotherapy},
journal = {Hépato-Gastro & Oncologie Digestive},
year = {2026},
volume = {33},
number = {6},
pages = {694--699},
doi = {10.1684/hpg.2026.3179}
}
EUVIMED